ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
By enabling self-loading of peptides, the ProVE SL platform empowers immunologists to adapt their reagents more quickly to new antigens, for example for infectious diseases, cancer neo-antigens, ...
The FW500 Clinical Chemistry Analyzer marks a new entry into wet chemistry technology for mid-sized laboratories. The launch ...
Focusing on the methodological challenges in adapting tissue optical clearing technology to large animals, this review ...
(A) The Incucyte® Apoptosis Assay allows automated imaging and quantitative analysis of every well of a 96/384-well plate, ...
CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...
This report by Towards Healthcare, a sister firm of Precedence Research, offers an in-depth analysis of the contamination ...
Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...
As of the end of Q3, 12.7 hectares of geosynthetics were installed on the leach pad. This area guarantees a leach pad for six months of production capacity. Leach pad construction recommenced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results